News | Magnetic Resonance Imaging (MRI) | October 11, 2017

MR Solutions Showcases Multimodality MRI Solutions on Two Continents

Cryogen-free preclinical technology combines MRI with PET and SPECT for enhanced imaging

MR Solutions Showcases Multimodality MRI Solutions on Two Continents

October 11, 2017 — MR Solutions took their cryogen-free preclinical multimodality magnetic resonance imaging (MRI) solutions on tour in September 2017. The company had exhibits at the 23rd Annual Scientific Meeting of the British Chapter of the International Society for Magnetic Resonance in Medicine (Sept. 11-13), and the British Nuclear Medicine Society’s autumn meeting (Sept. 15), both held in Liverpool. The company also exhibited at the World Molecular Imaging Congress 2017, Sept. 13-16 in Philadelphia.

MR Solutions, which is based in Guildford, U.K., is an independent developer and manufacturer of preclinical multimodality MRI technology and remains the only company to deliver a commercial cryogen-free 3T to 9.4T range of preclinical benchtop MRI scanners. In recognition of the company’s innovation and business acumen the company received the Queen’s Award for Enterprise twice – for innovation in 2016 and for international trade in 2017.

Multimodality imaging can provide researchers with one or more imaging techniques in parallel or in series for superior, quicker imaging results. To provide the single photon emission computed tomography (SPECT) images, MR Solutions has devised a system where the four gamma camera heads and focusing collimator can be easily clipped on to the front of the bore of the MRI scanner to provide state-of-the-art 3-D SPECT images. The SPECT images can be registered with the MRI images, providing anatomical-functional combined capability. The SPECT gamma camera can also be used independently.

The positron emission tomography (PET) capability is provided by solid-state detectors which are incorporated in the bore of the MRI scanner. The scanner combines the structural and functional characterization of tissue provided by MRI with the extreme sensitivity of PET imaging for metabolism and tracking of uniquely labelled cell types or cell receptors. This is particularly useful in oncology, cardiology and neurology research.

For more information: www.mrsolutions.com

Related Content

Toshiba Vantage Galan 3T XGO Edition MRI Features New Advanced Gradient
Technology | Magnetic Resonance Imaging (MRI)| December 11, 2017
Toshiba Medical, a Canon Group company, demonstrated the Vantage Galan 3T XGO Edition with the all-new Saturn X...
Toshiba Launches Vantage Elan Zen Edition MR for Enhanced Patient Comfort
Technology | Magnetic Resonance Imaging (MRI)| December 05, 2017
Toshiba Medical, a Canon Group company, introduced its newest magnetic resonance (MR) system, the Vantage Elan/Zen...
Vital Unveils Newest Vitrea Advanced Visualization Release at RSNA 2017
Technology | Advanced Visualization| December 04, 2017
December 4, 2017 — Vital Images unveiled the newest version of Vitrea...
Samsung Unveils Mobile CT OmniTom at RSNA 2017
Technology | Computed Tomography (CT)| November 26, 2017
Samsung Electronics debuted its OmniTom mobile 16-slice computed tomography (CT) scanner at the Radiological Society of...
Siemens Healthineers Introduces Share360 Tailored Service Portfolio
News | Cardiac Imaging| November 10, 2017
To address the specific needs of medical imaging clinical engineering departments nationwide, Siemens Healthineers has...
MRI May Predict Neurological Outcomes for Cardiac Arrest Survivors
News | Sudden Cardiac Arrest| October 18, 2017
Magnetic resonance imaging (MRI)-based measurements of the functional connections in the brain can help predict long-...
ASNC and ASE Team Up to Expand ImageGuide Registry
News | Cardiovascular Ultrasound| October 12, 2017
The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced...
FDA Clears Siemens Magnetom Terra 7T MRI Device

The FDA has cleared the Siemens Magnetom Terra as the first 7T MRI system in the U.S. to gain regulatory approval.

Technology | Magnetic Resonance Imaging (MRI)| October 12, 2017
The U.S. Food and Drug Administration (FDA) cleared the first 7 Tesla (7T) magnetic resonance imaging (MRI) device,...
Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD)| September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Overlay Init